22 May 2013
Keywords: gpc, biotech, aiming, build, broad, oncology, pipeline
Article | 24 November 2003
In an interview with the Marketletter, Bernd Seizinger, chief executiveat GPC Biotech, provided an update of the company's pipeline and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 November 2003
24 November 2003
© 2013 thepharmaletter.com